Lynette J Tippett, Erin E Cawston, Catherine A Morgan, Tracy R Melzer, Kiri L Brickell, Christina Ilse, Gary Cheung, Ian J Kirk, Reece P Roberts, Jane Govender, Leon Griner, Campbell Le Heron, Sarah Buchanan, Waiora Port, Makarena Dudley, Tim J Anderson, Joanna M Williams, Nicholas J Cutfield, John C Dalrymple-Alford, Phil Wood
{"title":"痴呆症预防研究诊所:一项纵向研究,调查新西兰奥特亚影响阿尔茨海默病发展的因素","authors":"Lynette J Tippett, Erin E Cawston, Catherine A Morgan, Tracy R Melzer, Kiri L Brickell, Christina Ilse, Gary Cheung, Ian J Kirk, Reece P Roberts, Jane Govender, Leon Griner, Campbell Le Heron, Sarah Buchanan, Waiora Port, Makarena Dudley, Tim J Anderson, Joanna M Williams, Nicholas J Cutfield, John C Dalrymple-Alford, Phil Wood","doi":"10.1080/03036758.2022.2098780","DOIUrl":null,"url":null,"abstract":"<p><p>Aotearoa New Zealand's population is ageing. Increasing life expectancy is accompanied by increases in prevalence of Alzheimer's Disease (AD) and ageing-related disorders. The multicentre Dementia Prevention Research Clinic longitudinal study aims to improve understanding of AD and dementia in Aotearoa, in order to develop interventions that delay or prevent progression to dementia. Comprising research clinics in Auckland, Christchurch and Dunedin, this multi-disciplinary study involves community participants who undergo biennial investigations informed by international protocols and best practice: clinical, neuropsychological, neuroimaging, lifestyle evaluations, <i>APOE</i> genotyping, blood collection and processing. A key research objective is to identify a 'biomarker signature' that predicts progression from mild cognitive impairment to AD. Candidate biomarkers include: blood proteins and microRNAs, genetic, neuroimaging and neuropsychological markers, health, cultural, lifestyle, sensory and psychosocial factors. We are examining a range of mechanisms underlying the progression of AD pathology (e.g. faulty blood-brain barrier, excess parenchymal iron, vascular dysregulation). This paper will outline key aspects of the Dementia Prevention Research Clinic's research, provide an overview of data collection, and a summary of 266 participants recruited to date. The national outreach of the clinics is a strength; the heart of the Dementia Prevention Research Clinics are its people.</p>","PeriodicalId":49984,"journal":{"name":"Journal of the Royal Society of New Zealand","volume":"53 1","pages":"489-510"},"PeriodicalIF":2.1000,"publicationDate":"2022-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459802/pdf/","citationCount":"0","resultStr":"{\"title\":\"Dementia Prevention Research Clinic: a longitudinal study investigating factors influencing the development of Alzheimer's disease in Aotearoa, New Zealand.\",\"authors\":\"Lynette J Tippett, Erin E Cawston, Catherine A Morgan, Tracy R Melzer, Kiri L Brickell, Christina Ilse, Gary Cheung, Ian J Kirk, Reece P Roberts, Jane Govender, Leon Griner, Campbell Le Heron, Sarah Buchanan, Waiora Port, Makarena Dudley, Tim J Anderson, Joanna M Williams, Nicholas J Cutfield, John C Dalrymple-Alford, Phil Wood\",\"doi\":\"10.1080/03036758.2022.2098780\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Aotearoa New Zealand's population is ageing. Increasing life expectancy is accompanied by increases in prevalence of Alzheimer's Disease (AD) and ageing-related disorders. The multicentre Dementia Prevention Research Clinic longitudinal study aims to improve understanding of AD and dementia in Aotearoa, in order to develop interventions that delay or prevent progression to dementia. Comprising research clinics in Auckland, Christchurch and Dunedin, this multi-disciplinary study involves community participants who undergo biennial investigations informed by international protocols and best practice: clinical, neuropsychological, neuroimaging, lifestyle evaluations, <i>APOE</i> genotyping, blood collection and processing. A key research objective is to identify a 'biomarker signature' that predicts progression from mild cognitive impairment to AD. Candidate biomarkers include: blood proteins and microRNAs, genetic, neuroimaging and neuropsychological markers, health, cultural, lifestyle, sensory and psychosocial factors. We are examining a range of mechanisms underlying the progression of AD pathology (e.g. faulty blood-brain barrier, excess parenchymal iron, vascular dysregulation). This paper will outline key aspects of the Dementia Prevention Research Clinic's research, provide an overview of data collection, and a summary of 266 participants recruited to date. The national outreach of the clinics is a strength; the heart of the Dementia Prevention Research Clinics are its people.</p>\",\"PeriodicalId\":49984,\"journal\":{\"name\":\"Journal of the Royal Society of New Zealand\",\"volume\":\"53 1\",\"pages\":\"489-510\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2022-08-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459802/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Royal Society of New Zealand\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.1080/03036758.2022.2098780\",\"RegionNum\":4,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Royal Society of New Zealand","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1080/03036758.2022.2098780","RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
Dementia Prevention Research Clinic: a longitudinal study investigating factors influencing the development of Alzheimer's disease in Aotearoa, New Zealand.
Aotearoa New Zealand's population is ageing. Increasing life expectancy is accompanied by increases in prevalence of Alzheimer's Disease (AD) and ageing-related disorders. The multicentre Dementia Prevention Research Clinic longitudinal study aims to improve understanding of AD and dementia in Aotearoa, in order to develop interventions that delay or prevent progression to dementia. Comprising research clinics in Auckland, Christchurch and Dunedin, this multi-disciplinary study involves community participants who undergo biennial investigations informed by international protocols and best practice: clinical, neuropsychological, neuroimaging, lifestyle evaluations, APOE genotyping, blood collection and processing. A key research objective is to identify a 'biomarker signature' that predicts progression from mild cognitive impairment to AD. Candidate biomarkers include: blood proteins and microRNAs, genetic, neuroimaging and neuropsychological markers, health, cultural, lifestyle, sensory and psychosocial factors. We are examining a range of mechanisms underlying the progression of AD pathology (e.g. faulty blood-brain barrier, excess parenchymal iron, vascular dysregulation). This paper will outline key aspects of the Dementia Prevention Research Clinic's research, provide an overview of data collection, and a summary of 266 participants recruited to date. The national outreach of the clinics is a strength; the heart of the Dementia Prevention Research Clinics are its people.
期刊介绍:
Aims: The Journal of the Royal Society of New Zealand reflects the role of Royal Society Te Aparangi in fostering research and debate across natural sciences, social sciences, and the humanities in New Zealand/Aotearoa and the surrounding Pacific. Research published in Journal of the Royal Society of New Zealand advances scientific knowledge, informs government policy, public awareness and broader society, and is read by researchers worldwide.